Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023579272> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3023579272 endingPage "1474" @default.
- W3023579272 startingPage "1469" @default.
- W3023579272 abstract "To determine the time course and duration of common, early-onset treatment-emergent adverse events (TEAEs) associated with sodium oxybate (SXB) use in adults with narcolepsy.These were post hoc analyses of two 8-week, randomized, double-blind, placebo-controlled trials. In SXB-15, participants (n = 246) received daily placebo (n = 60) or SXB (n = 186) initiated at 4.5 g. Participants assigned to SXB 6 or 9 g were titrated in 1.5-g increments. In SXB-22, participants entering on modafinil (n = 231) received placebo (n = 56), SXB (n = 55), modafinil (n = 63), or SXB and modafinil (n = 57). SXB was initiated at 6 g for weeks 1-4 and increased to 9 g for weeks 5-8. TEAEs reported more frequently in SXB-treated participants than placebo and in ≥5% of any SXB treatment group during week 1 were examined as TEAEs of interest.Dizziness and nausea met criteria as TEAEs of interest in both studies; headache also met criteria as a TEAE of interest in SXB-15. Incidence of new or worsened TEAEs was highest at week 1 (SXB-15: dizziness, 7.5%; headache, 7.5%; nausea, 5.9%; SXB-22: dizziness, 5.4%; nausea, 7.1%) and decreased over time in both studies. The longest median duration was reported for dizziness: 9.0 and 17.5 days in SXB-15 and SXB-22, respectively. Dizziness caused discontinuation in 2.2% and 3.6% of participants in SXB-15 and SXB-22, respectively; nausea caused discontinuation in 2.7% and 1.8%.Common early-onset TEAEs associated with SXB treatment were generally of short duration and their incidence decreased over time. These TEAEs accounted for few discontinuations overall.Registry: ClinicalTrials.gov; Names: Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients; Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy; URLs: https://clinicaltrials.gov/ct2/show/NCT00049803 and https://clinicaltrials.gov/ct2/show/NCT00066170; Identifiers: NCT00049803 and NCT00066170." @default.
- W3023579272 created "2020-05-13" @default.
- W3023579272 creator A5005484428 @default.
- W3023579272 creator A5026972521 @default.
- W3023579272 creator A5048443892 @default.
- W3023579272 creator A5060470363 @default.
- W3023579272 creator A5082457988 @default.
- W3023579272 creator A5089333547 @default.
- W3023579272 date "2020-09-15" @default.
- W3023579272 modified "2023-10-02" @default.
- W3023579272 title "Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy" @default.
- W3023579272 cites W2054547728 @default.
- W3023579272 cites W2394759316 @default.
- W3023579272 cites W2408723248 @default.
- W3023579272 cites W2528922120 @default.
- W3023579272 cites W2611262353 @default.
- W3023579272 cites W2827053459 @default.
- W3023579272 cites W2936903227 @default.
- W3023579272 cites W4239272726 @default.
- W3023579272 cites W4248551691 @default.
- W3023579272 cites W4255769218 @default.
- W3023579272 cites W4292110643 @default.
- W3023579272 doi "https://doi.org/10.5664/jcsm.8530" @default.
- W3023579272 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7970612" @default.
- W3023579272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32356515" @default.
- W3023579272 hasPublicationYear "2020" @default.
- W3023579272 type Work @default.
- W3023579272 sameAs 3023579272 @default.
- W3023579272 citedByCount "6" @default.
- W3023579272 countsByYear W30235792722022 @default.
- W3023579272 countsByYear W30235792722023 @default.
- W3023579272 crossrefType "journal-article" @default.
- W3023579272 hasAuthorship W3023579272A5005484428 @default.
- W3023579272 hasAuthorship W3023579272A5026972521 @default.
- W3023579272 hasAuthorship W3023579272A5048443892 @default.
- W3023579272 hasAuthorship W3023579272A5060470363 @default.
- W3023579272 hasAuthorship W3023579272A5082457988 @default.
- W3023579272 hasAuthorship W3023579272A5089333547 @default.
- W3023579272 hasBestOaLocation W30235792721 @default.
- W3023579272 hasConcept C118552586 @default.
- W3023579272 hasConcept C126322002 @default.
- W3023579272 hasConcept C142724271 @default.
- W3023579272 hasConcept C187212893 @default.
- W3023579272 hasConcept C197934379 @default.
- W3023579272 hasConcept C204787440 @default.
- W3023579272 hasConcept C27081682 @default.
- W3023579272 hasConcept C2778715236 @default.
- W3023579272 hasConcept C2779494582 @default.
- W3023579272 hasConcept C2780580376 @default.
- W3023579272 hasConcept C2780714222 @default.
- W3023579272 hasConcept C42219234 @default.
- W3023579272 hasConcept C71924100 @default.
- W3023579272 hasConceptScore W3023579272C118552586 @default.
- W3023579272 hasConceptScore W3023579272C126322002 @default.
- W3023579272 hasConceptScore W3023579272C142724271 @default.
- W3023579272 hasConceptScore W3023579272C187212893 @default.
- W3023579272 hasConceptScore W3023579272C197934379 @default.
- W3023579272 hasConceptScore W3023579272C204787440 @default.
- W3023579272 hasConceptScore W3023579272C27081682 @default.
- W3023579272 hasConceptScore W3023579272C2778715236 @default.
- W3023579272 hasConceptScore W3023579272C2779494582 @default.
- W3023579272 hasConceptScore W3023579272C2780580376 @default.
- W3023579272 hasConceptScore W3023579272C2780714222 @default.
- W3023579272 hasConceptScore W3023579272C42219234 @default.
- W3023579272 hasConceptScore W3023579272C71924100 @default.
- W3023579272 hasIssue "9" @default.
- W3023579272 hasLocation W30235792721 @default.
- W3023579272 hasLocation W30235792722 @default.
- W3023579272 hasLocation W30235792723 @default.
- W3023579272 hasLocation W30235792724 @default.
- W3023579272 hasOpenAccess W3023579272 @default.
- W3023579272 hasPrimaryLocation W30235792721 @default.
- W3023579272 hasRelatedWork W2040480454 @default.
- W3023579272 hasRelatedWork W2081317204 @default.
- W3023579272 hasRelatedWork W2104761597 @default.
- W3023579272 hasRelatedWork W2151237973 @default.
- W3023579272 hasRelatedWork W2509102166 @default.
- W3023579272 hasRelatedWork W282266550 @default.
- W3023579272 hasRelatedWork W3023579272 @default.
- W3023579272 hasRelatedWork W3037606875 @default.
- W3023579272 hasRelatedWork W3172359983 @default.
- W3023579272 hasRelatedWork W2183331092 @default.
- W3023579272 hasVolume "16" @default.
- W3023579272 isParatext "false" @default.
- W3023579272 isRetracted "false" @default.
- W3023579272 magId "3023579272" @default.
- W3023579272 workType "article" @default.